TY - JOUR
T1 - Multivisceral Transplantation. Where Do We Stand?
AU - Bhamidimarri, Kalyan Ram
AU - Beduschi, Thiago
AU - Vianna, Rodrigo
PY - 2014/8
Y1 - 2014/8
N2 - Intestinal transplantation is the definitive therapy for patients with irreversible intestinal failure and can be combined with transplantation of other abdominal organs, such as stomach, spleen, and pancreas with or without liver. There is an increasing trend in the volume of intestinal and multivisceral transplantation in the past few decades and there is also increasing trend in patient and graft survival primarily due to improved patient selection, advances in immunosuppression, and improved perioperative management. This review summarizes the various key elements in patient selection, types of grafts, and updates in the perioperative management involved in multivisceral transplantation.
AB - Intestinal transplantation is the definitive therapy for patients with irreversible intestinal failure and can be combined with transplantation of other abdominal organs, such as stomach, spleen, and pancreas with or without liver. There is an increasing trend in the volume of intestinal and multivisceral transplantation in the past few decades and there is also increasing trend in patient and graft survival primarily due to improved patient selection, advances in immunosuppression, and improved perioperative management. This review summarizes the various key elements in patient selection, types of grafts, and updates in the perioperative management involved in multivisceral transplantation.
KW - Intestinal failure
KW - Intestinal transplantation
KW - Liver transplantation
KW - Multivisceral transplantation
UR - http://www.scopus.com/inward/record.url?scp=84903943703&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84903943703&partnerID=8YFLogxK
U2 - 10.1016/j.cld.2014.05.008
DO - 10.1016/j.cld.2014.05.008
M3 - Review article
C2 - 25017082
AN - SCOPUS:84903943703
VL - 18
SP - 661
EP - 674
JO - Clinics in Liver Disease
JF - Clinics in Liver Disease
SN - 1089-3261
IS - 3
ER -